GRAL vs SHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SHC Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sotera Health Company Common Stock (SHC) driven by superior Growth & Margin, Options & Structure while GRAL counters with relative strength in Valuation, Momentum & Technical. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus SHC at 15.3x Forward P/E and 36.8% operating margin (+4.4% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against SHC sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GRAL | SHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $4.7B | Larger Scale | GRAL |
| Trailing P/E Ratio Valuation | 1.1x | 27.7x | Lower Multiple | GRAL |
| Forward P/E Ratio Valuation | 1.1x | 15.3x | Lower Multiple | GRAL |
| Revenue Growth (YoY) Growth | +3.7% | +4.4% | Higher Growth | SHC |
| Operating Margin (TTM) Profitability | -332.0% | 36.8% | Higher Margin | SHC |
| Net Profit Margin Profitability | -243.8% | 14.1% | Higher Margin | SHC |
| Return on Equity (ROE) Capital Efficiency | -17.3% | 27.0% | Higher ROE | SHC |
| 52-Week Range Position Momentum | 51% ($42โ$166) | 47% ($13โ$20) | Stronger Trend | GRAL |
| Beta / 30D Volatility Risk Regime | 3.09ฮฒ ยท 99% Vol | 0.95ฮฒ ยท 44% Vol | Lower Realized Risk | SHC |
| Unified Institutional Score Composite Signal | 54.5 / 100 (HOLD) | 63.1 / 100 (BUY) | Higher Composite | SHC |